Healthcare -
Medical - Pharmaceuticals - NASDAQ - US
$ 11.5001
-0.174 %
$ 9.95 B
Market Cap
-1.58
P/E
1. INTRINSIC VALUE
Balance Sheet
Walgreens Boots Alliance, Inc.
| Current Assets | 18.3 B |
| Cash & Short-Term Investments | 3.11 B |
| Receivables | 5.85 B |
| Other Current Assets | 9.38 B |
| Non-Current Assets | 62.7 B |
| Long-Term Investments | 2.27 B |
| PP&E | 30.1 B |
| Other Non-Current Assets | 30.3 B |
| Current Liabilities | 27 B |
| Accounts Payable | 14.1 B |
| Short-Term Debt | 2.46 B |
| Other Current Liabilities | 10.4 B |
| Non-Current Liabilities | 41.9 B |
| Long-Term Debt | 29.9 B |
| Other Non-Current Liabilities | 12 B |
EFFICIENCY
Earnings Waterfall
Walgreens Boots Alliance, Inc.
| Revenue | 148 B |
| Cost Of Revenue | 121 B |
| Gross Profit | 26.5 B |
| Operating Expenses | 40.6 B |
| Operating Income | -14.1 B |
| Other Expenses | 1.37 B |
| Net Income | -15.4 B |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Walgreens Boots Alliance, Inc.
| Net Income | -15.4 B |
| Depreciation & Amortization | 2.46 B |
| Capital Expenditures | -1.38 B |
| Stock-Based Compensation | 182 M |
| Change in Working Capital | -486 M |
| Others | 12 B |
| Free Cash Flow | -363 M |
Wall Street Analysts Price Targets
Walgreens Boots Alliance, Inc.
Wall Street analysts predict an average 1-year price target for WBA of $10.7 , with forecasts ranging from
a
low of
$7.5 to a high of $16 .
WBA Lowest Price Target
Wall Street Target
7.5 USD
-34.78%
WBA Average Price Target
Wall Street Target
10.7 USD
-7.39%
WBA Highest Price Target
Wall Street Target
16 USD
39.13%
4. DIVIDEND
ANALYSIS
0.00%
DIVIDEND YIELD
0.25 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Walgreens Boots Alliance, Inc.
Sold
0-3 MONTHS
9.16 M USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
9.16 M USD 1
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Popular Grocery Chain Plans To Add Clinton Store
CLINTON, CT — An ALDI grocery store is planned for a site in Clinton. The store is being advertised in a real estate flyer for a site at 224 to 230 E. Main St. Tyler Lyman, of True Commercial Real Estate, LLC, said that there is no opening date yet for the store. The store is expected to be 20,664 square ft. Parking at the site will be between 105 and 110 spaces. No plans have been filed with the town. Plans are still subject to local approvals, according to The Connecticut Scoop. The real estate flyer notes that the center is "in the heart of Clinton's 'daily needs' retail district and conveniently located on Route 1 and only minutes from I-95." There are available spaces at the site for lease that are 2,500 square feet and 7,150 square feet, respectively. Other area retailers include Stop & Shop, Auto Zone, Walgreens, Dunkin', Shop Rite, and Advance Auto Parts. ALDI did not respond to a request for comment. The popular discount grocer currently has over 30 locations across the state. The company has set its eyes on a few possible locations for future stores in Connecticut. In Stratford, reports indicate a new ALDI grocery store is being proposed to be built at the Stratford Square shopping plaza on Barnum Avenue. A public hearing regarding the possible addition of an ALDI discount grocery store on Route 5 in East Windsor was held in April. A new mixed-use plaza with an ALDI and a Starbucks was also proposed in Stonington. Related: Beloved Grocery Store With Over 30 CT Stores Drops Prices On Hundreds Of Items New Aldi Store Proposed In Stratford: Report Grocery Store, Coffee Shop, Massive Residential Development Pitched For Stonington
https://www.patch.com
- 1 week ago
Two Quality Stocks Whose Price Declines May Be Long-Term Buying Opportunities
Recent stock price pullbacks in two companies present potential buying opportunities for long-term investors, despite no obvious negative news. I emphasize the importance of distinguishing between temporary dips and fundamental business issues, referencing Warren Buffett's advice. T-Mobile's pullback offers a buying opportunity due to strong earnings growth, robust free cash flow, aggressive buybacks, and double-digit dividend increases.
seekingalpha.com
- 1 week ago
Premier Medical Collaborates with Walgreens to Expand Access to Care Across Central Florida
ORLANDO, Fla.--(BUSINESS WIRE)--Premier Medical, a leading primary and multispecialty care provider in Central Florida, today announces a new collaboration with Walgreens to increase access to high-quality healthcare in local communities. Beginning this summer, Premier Medical, which is a part of the value-driven healthcare company, NeueHealth, will begin operating clinics inside select Walgreens locations, starting with two sites opening in Davenport, Fla., and Orlando, Fla., in July 2025. The.
businesswire.com
- 1 week ago
Walgreens Takes Major Step Toward Becoming Private Company Again
Walgreens Boots Alliance Inc. has taken a major step forward in its bid to go private after it announced that at the Company's Special Meeting of Shareholders, WBA shareholders had approved the previously announced acquisition of the company by entities affiliated with Sycamore Partners Management.
forbes.com
- 1 week ago
Walgreens Shareholders Approve $10 Billion Private Equity Buyout
Walgreens Boots Alliance shareholders Friday approved private equity firm Sycamore Partners' $10 billion buyout offer for the iconic drugstore chain.
forbes.com
- 2 weeks ago
Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the “Company” or “WBA”) today announced that at the Company's Special Meeting of Shareholders (the “Special Meeting”), WBA shareholders approved the previously announced acquisition of the Company by entities affiliated with Sycamore Partners Management, L.P. (“Sycamore”). According to the preliminary results, approximately 96% of votes cast at the Special Meeting by all shareholders were voted in favor of the merge.
businesswire.com
- 2 weeks ago
3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years
Normally, a buy-and-hold strategy pays off, and investors expect to see strong gains from their investments. The S&P 500 (^GSPC -0.79%) has risen by 200% over the past decade, and mirroring the index would have enabled you to triple your money.
fool.com
- 2 weeks ago
Cash Flow Matters: Two Cheap Stocks With Relatively Secure Dividends And Upside Potential
Despite new S&P highs, I expect continued market volatility and see a 50/50 chance of recession in the next 6–12 months. The Fed's reluctance to cut rates, ongoing trade tensions, and potential stagflation keep me cautious, even as market sentiment turns greedy. Realty Income remains attractive for dividend investors due to its diversified portfolio, strong balance sheet, and proactive management despite tenant challenges.
seekingalpha.com
- 2 weeks ago
3 Things You Need to Know If You Buy Walgreens Today
Walgreens Boots Alliance (WBA -0.13%) is one of the largest pharmacy retailers in the United States. Over the past several years, the company has made a number of poor investment decisions.
fool.com
- 3 weeks ago
Walgreens Outlook Improves As Buyout Faces Shareholder Vote Next Month
News that Walgreens Boots Alliance quarterly loss was better than expected and pharmacy sales are rising bodes well for a financial turnaround under new private equity ownership.
forbes.com
- 4 weeks ago
Walgreens Sales Rise but CEO Says Turnaround Will ‘Take Time'
Walgreens is reportedly seeing an uptick in sales as it prepares to go private. [contact-form-7] The company released quarterly earnings Thursday (June 26) showing sales of $39 billion, a 7.2% increase from the same quarter last year, driven by growth in its American retail pharmacy and international segments.
pymnts.com
- 4 weeks ago
Crude Oil Gains Over 1%; Walgreens Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.
benzinga.com
- 4 weeks ago
8. Profile
Summary
Walgreens Boots Alliance, Inc. WBA
COUNTRY
US
INDUSTRY
Medical - Pharmaceuticals
MARKET CAP
$ 9.95 B
Dividend Yield
0.00%
Description
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Contact
108 Wilmot Road, Deerfield, IL, 60015
https://www.walgreensbootsalliance.com
IPO
Date
March 17, 1980
Employees
193000
Officers
Mr. Stefano Pessina
Executive Chairman of the Board
Mr. Matthew D'Ambrosio
Senior Vice President and Global Chief Compliance & Ethics Officer
Mr. Manmohan Mahajan
Executive Vice President & Global Chief Financial Officer
Mr. Todd D. Heckman
Senior Vice President, Global Controller & Chief Accounting Officer
Ms. Elizabeth L. Burger
Executive Vice President & Chief Human Resources Officer
Ms. Lanesha T. Minnix J.D.
Executive Vice President & Global Chief Legal Officer
Ms. Ornella Barra
Chief Operating Officer of International
Mr. Timothy C. Wentworth
Chief Executive Officer & Director
Dr. Neal Joseph Sample Ph.D.
Executive Vice President & Chief Information Officer
Ms. Mary Langowski
Executive Vice President & President of Walgreens Health